METHODS: ERG readings, ABR testing, fundus morphology, histological examination of the retina and inner ear, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis, western blotting, DNA sequence analysis and behavioural experiments were performed to assess the phenotypes and genotypes of the progeny lines.
RESULTS: No obvious waveforms in the ERG were detected in F1 hybrid mice while normal ABR results were recorded. The F2 hybrids, which were called J1ush/ush or J2ush/ush, exhibited segregated hearing-loss phenotypes. J1ush/ush mice had a retinitis pigmentosa (RP) phenotype with elevated ABR thresholds, whereas J2ush/ush mice exhibited only the RP phenotype. Interestingly, J1ush/ush mice showed significantly higher ABR thresholds than wild-type mice at 28 days post born (P28), and RT-qPCR and DNA-sequencing analysis showed that Adgrv1 gene expression was significantly altered in J1ush/ush mice, but histological analysis showed no significant structural changes in the organ of Corti or spiral ganglia. Further elevation of ABR-related hearing thresholds by P56 manifested only as a reduced density of spiral ganglion cells, which differed significantly from the previous pattern of cochlear alterations in CBA-2ush/ush mice.
CONCLUSIONS: We successfully introduced the hearing-loss phenotype of inbred mice with USH into CBA/J mice, which provides a good animal model for future studies on the important physiological roles of the Adgrv1 gene in inner-ear structure and for therapeutic studies targeting Adgrv1-mutated USH.
方法:ERG读数,ABR测试,眼底形态学,视网膜和内耳的组织学检查,逆转录-定量聚合酶链反应(RT-qPCR)分析,西方印迹,进行DNA序列分析和行为实验以评估后代系的表型和基因型。
结果:在F1杂种小鼠的ERG中未检测到明显的波形,而记录到正常的ABR结果。F2杂种,它们被称为J1ush/ush或J2ush/ush,表现出隔离的听力损失表型。J1ush/ush小鼠具有视网膜色素变性(RP)表型,ABR阈值升高,而J2ush/ush小鼠仅表现出RP表型。有趣的是,J1ush/ush小鼠在出生后28天表现出明显高于野生型小鼠的ABR阈值(P28),RT-qPCR和DNA测序分析表明,J1ush/ush小鼠的Adgrv1基因表达显著改变,但是组织学分析显示Corti或螺旋神经节器官没有明显的结构变化。通过P56进一步提高ABR相关的听力阈值仅表现为螺旋神经节细胞的密度降低,与CBA-2ush/ush小鼠的耳蜗改变模式显着不同。
结论:我们成功地将USH近交系小鼠的听力损失表型引入CBA/J小鼠,这为未来研究Adgrv1基因在内耳结构中的重要生理作用以及针对Adgrv1突变USH的治疗研究提供了良好的动物模型。